EN
HI
Alkem Laboratories share price chart
Alkem Laboratories Share Key Metrics
Volume
88646.00
Market Cap
68110.20 CR
LTQ@LTP
1@5696.50
ATP
5628.74
Var Margin
12.54 %
Circuit Range
5047.5-6168.5
Delivery %
54.39 %
Value
49.90 CR
ASM/GSM
No
Market Lot
1
Summary
ALKEM stock price is ₹5696.5 as of 5 Aug, 2026. The stock intraday movement has stayed between ₹5556.00 and ₹5696.50, while Alkem Laboratories share price 52 week high low is ₹4738.50 & ₹5933.50.
In terms of trading activity, ALKEM share price has recorded a volume of 88,646 shares. The Alkem Laboratories has a market cap of ₹119565000. The stock’s Average Traded Price (ATP) stands at ₹5628.74, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹5696.50.
The Alkem Laboratories upper circuit limit is ₹6168.50 & The Alkem Laboratories lower circuit limit is ₹5047.50, with a Value of ₹49.90 CR. The Delivery Percentage for the day is 54.39%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Alkem Laboratories Fundamentals
P/E Ratio
28.57
P/B Ratio
4.77
Div. Yield
0.96
Sector P/E
64.89
Sector P/B
3.24
Sec. Div. Yield
0.52
Alkem Laboratories Resistance and Support
Pivot 5642
Resistance
First Resistance
5676
Second Resistance
5744
Third Resistance
5778
Support
First Support
5574
Second Support
5540
Third Support
5472
Alkem Laboratories Futures & Options
Alkem Laboratories Option Chain
View Price, OI, Greeks & More...
25AUG26
5692.00
12.00 (0.21%)
29SEP26
5705.00
7.00 (0.12%)
27OCT26
5708.00
-34.00 (0.59%)
ALKEM|25AUG26 CE 5650.00
181.00
1 (0.56%)
ALKEM|25AUG26 PE 5700.00
159
-14.6 (-8.41%)
Alkem Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 05 2026 | 5620.5 | 5696.5 | 1.58% | 5696.5 | 5556 |
| Tue Aug 04 2026 | 5699 | 5608 | -1.73% | 5710 | 5608 |
| Mon Aug 03 2026 | 5774.5 | 5707 | -0.77% | 5774.5 | 5668 |
Alkem Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-28 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results & Interim Dividend |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-07 | Quarterly Results & Interim Dividend |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Alkem Laboratories News
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Alkem Laboratories' wholly-owned Indian subsidiary, Alkem Medtech, completed the acquisition of 51-55% equity share capital in Switzerland-based Occlutech Holding AG. Occlutech will now operate as a step-down subsidiary, expanding the company's business scope.
Jul 17 2026 18:10:04
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Acquisition
Alkem Laboratories' wholly-owned subsidiary, Alkem Medtech Private Limited, is set to acquire a 51-55% stake in Occlutech Holding AG. Alkem Labs has invested Rs.1,100 crore into Alkem Medtech by subscribing to its rights shares, to facilitate this strategic acquisition, which expands its presence in the medical device segment.
Jul 16 2026 14:58:06
Read More
Alkem Laboratories Management
| Name | Position |
|---|---|
| Neela Bhattacherjee | Non Executive Independent Director |
| Manish Narang | President – Legal, Company Secretary & Compliance Officer |
Alkem Laboratories Similar Stocks
Aurobindo Pharma Ltd.
1613.40
27.50 (1.73%)
Fortis Healthcare Ltd.
925.00
-7.80 (0.84%)
Aster DM Quality Care Ltd.
842.10
7.40 (0.89%)
Biocon Ltd.
425.20
3.20 (0.76%)
Glenmark Pharmaceuticals Ltd.
2259.00
34.00 (1.53%)
Abbott India Ltd.
27785.00
-40.00 (0.14%)
Anthem Biosciences Ltd.
825.65
6.40 (0.78%)
Glaxosmithkline Pharmaceuticals Ltd.
2569.70
-77.30 (2.92%)
Alkem Laboratories FAQs
The Buying Price of Alkem Laboratories share is 5696.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alkem Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alkem Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alkem Laboratories shares is 28.57. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alkem Laboratories shares is 4.77. Useful to assess the stock's value relative to its book value.
To assess Alkem Laboratories’s valuation compare Sector P/E, P/B which are 64.89 & 3.24 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alkem Laboratories is 68110.20 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alkem Laboratories share price is 5933.50 & 4738.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alkem Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
